Ann: Bods exclusive partner iX Biopharma secures China patent, page-4

Some pretty serious commercial progress happening behind the scenes regarding BDAs medical cannabis strategy. Multi pronged progress.

This management team are well placed to capitalise on future exponential growth in the MM sector as consumers begin to adopt and uptake MM products.

Now that our partners patents are protected across Asia and specifically China and Daigou relationships strengthening, one can hope that this will flow through our sales and revenue streams.

Big tick here today for the progress BDA has made.

Still lots to do until that major rerate that we are all waiting for